Reena Mehra, MD
Pulmonary Disease · Seattle, WANPI 1578583290
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,814 of the $36,061 with a category attached, or 74.4%. 10 manufacturers reported payments, led by Lilly USA, LLC at 35.6% of the total. Reporting peaked in 2019 at $16,592 and has fallen 91.1% since, to $1,481 in 2025. Among pulmonary disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $680.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$13K
- Merck$11K
- ZOLL Respicardia, Inc.$5K
- Eli Lilly$4K
- Amgen$1K
- Jazz Pharmaceuticals Inc.$561
- plus $533 from 4 others
Across 37 payments — averaging $4745.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$175K
- Kyowa Kirin, Inc.$1K
What the payments were for
- Consulting fees$26,81474%
- Speaking & faculty fees$2,5007%
- Travel & lodging$4,68013%
- Food & beverage$2,0676%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $12,854 |
| Merck | 15 | $11,498 |
| ZOLL Respicardia, Inc. | 4 | $5,301 |
| Eli Lilly | 1 | $4,000 |
| Amgen | 1 | $1,314 |
| Jazz Pharmaceuticals Inc. | 7 | $561 |
| Intuitive Surgical | 2 | $238 |
| Boston Scientific | 1 | $125 |
| Body Vision Medical Inc. | 1 | $111 |
| Visionair Solutions, LLC | 1 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPBOUND$11,383
- remede System$5,301
- Da Vinci Surgical System$146
- Alair Bronchial Thermoplasty RF Controller$125
- LungVision$111
- XYWAV$109
How this compares
$36,061 in reported general payments places this provider in the 95th percentile of 275 pulmonary disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Seattle
- Jed GordenSeattle$236K
- Oneil BainsSeattle$156K
- Ganesh RaghuSeattle$147K
- Jeffrey CarySeattle$106K
- Amy DickeySeattle$71K
- Lawrence HoSeattle$70K
- Christopher GossSeattle$44K
- Rebecca SellSeattle$30K
- Peter LearySeattle$27K
- Mark WurfelSeattle$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.